Molnupiravir's real-world effectiveness in COVID-19 outpatients at high risk of severe disease: a single-center study

Molnupiravir's real-world effectiveness in COVID-19 outpatients at high risk of severe disease: a single-center study

Introduction: The coronavirus disease 2019 (COVID-19) pandemic started in March 2020. Since then, there has been an urgent need for effective therapeutic methods to manage the disease. We aimed to assess the effectiveness of molnupiravir in reducing the need for hospitalization in at-risk, non-hosp...

Full description

Saved in:
Bibliographic Details
Main Authors: Ivana I Gmizic, Aleksandra Barac, Nevena Todorovic, Milos Sabanovic, Natalija Kekic, Nikola Boskovic, Ankica Vujovic, Natasa Nikolic, Natasa Knezevic, Ivana Milosevic, Goran Stevanovic
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2024-05-01
Series:Journal of Infection in Developing Countries
Subjects:
molnupiravir
COVID-19
therapy
hospitalization
comorbidities
Online Access:https://jidc.org/index.php/journal/article/view/18802
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jidc.org/index.php/journal/article/view/18802

Similar Items